What sector does United Therapeutics belong to?
United Therapeutics operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of UTHR?
As of the latest available quote, UTHR traded at $497.11. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of UTHR?
United Therapeutics has a price-to-earnings (P/E) ratio of about 17.82. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of UTHR?
The market capitalisation of United Therapeutics is approximately $23.82B.
Is United Therapeutics profitable?
For its latest reported financial year, United Therapeutics recorded a net profit margin of about 41.94%.
Does UTHR pay a dividend?
United Therapeutics does not currently show a dividend yield in our data.
What is the return on equity (ROE) of UTHR?
United Therapeutics has a return on equity (ROE) of about 20.85%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of UTHR?
Over the past 52 weeks, UTHR has traded between a low of $396.12 and a high of $609.35.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.